Pharmacy Grand Rounds
Oral Antibiotics in Infective Endocarditis (IE): No Longer a Tough Pill to Swallow?

• ACPE Universal Activity Number (UAN): JA0000238-0000-20-028-L01-P
• Session Type: Knowledge-based
• CE Credits: A maximum of 0.75 contact hour (0.075 CEU) for the following: 
  • AAPA Category 1 CME Credits
  • ACPE
  • AMA PRA Category 1 Credits™
  • ANCC

• Session Fee: Free for Mayo Clinic staff

SESSION LOCATIONS

Live Session: (11:00am - 11:45am CST) 

Until future notice, learners must watch Pharmacy Grand Rounds live via the web by going to the Video Exchange and selecting “Pharmacy Grand Rounds” in the “Streaming Now” section.

Participants may attend by viewing: Live Webcast
Video Recording - access two weeks after session date

COURSE DESCRIPTION

The use of oral antimicrobials for complicated infections has been gaining significant interest in recent years. One such clinical scenario where this practice has been increasingly evaluated is the treatment of infective endocarditis. The 2015 Infectious Diseases Society of American clinical practice guideline for the treatment of infective endocarditis make mention that oral antibiotic treatment may be considered in a few specific situations. Since that time, the literature on this topic has continued to evolve, but the practice remains a topic of great debate. This presentation will review the most recent literature regarding oral antibiotics in infective endocarditis with the goal of shedding light on if, when, and in what patient populations oral therapy should be considered.

At the conclusion of this knowledge-based CE session, participants should be able to:

• Discuss current literature surrounding the use of oral antimicrobials in the treatment of IE
• Identify specific patient populations in whom it may be appropriate to consider oral therapy for the treatment of IE.
• Outline oral antimicrobial regimens which may be most appropriate for use in the treatment of IE

Session Announcement

Session Slides

FACULTY INFORMATION

Kyle S. Wamsley, PharmD
PGY1 Pharmacy Resident
Mayo Clinic Hospital - Rochester, MN

Kyle received a Doctor of Pharmacy degree from the University of Minnesota-Duluth and is a current PGY1 Pharmacy Resident at Mayo Clinic Hospital – Rochester. His clinical practice interests include critical care, cardiology, and infectious disease.  

DISCLOSURE STATEMENTS

As a provider accredited by Joint Accreditation Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science (Mayo Clinic School of CPD) must ensure balance, independence, objectivity and scientific rigor in its educational activities. Course Director(s), Planning Committee Members, Faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty also will disclose any off label and/or investigational use of pharmaceuticals or instruments discussed in their presentation. Disclosure of these relevant financial relationships will be published in activity materials so those participants in the activity may formulate their own judgments regarding the presentation.

Listed below are individuals with control of the content of this program:

The faculty report the following relationships:

• Kyle S. Wamsley, PharmD
  • Declares no financial relationships pertinent to this session
  • Declares off-label use of devices and medications will be discussed during this presentation, including;
    • Oral Antimicrobials used for IE

Course Director and Planning Committee Members declare no relevant financial relationship(s) pertinent to this session.  Members include:

• Brenda Amaris
• Mary Ellen Cordes, MS, APRN, CNC, NE-BC
• Michael Huckabee, MPAS, PA-C, PhD
• Wayne (Nick) Nicholson, MD, PharmD, BCPS
• Garrett Schramm, PharmD, BCPS
• Lee Skrupky, PharmD, BCPS